Core Points - Ackermans & van Haaren NV has increased its voting rights in Nextensa NV/SA to 80.31% following an acquisition of additional shares on 28 October 2025 [1][4] - As of 28 October 2025, Ackermans & van Haaren holds 68.13% of the total shares in Nextensa NV/SA [2] - The total number of voting rights held by Ackermans & van Haaren NV increased from 11,927,747 to 12,964,747, representing a change from 79.90% to 80.31% of the voting rights [4][5] Company Structure - Ackermans & van Haaren NV is controlled by Scaldis Invest NV, which is under Belgian law [6] - The ultimate controlling shareholder is Stichting Administratiekantoor 'Het Torentje', which acts on behalf of the aforementioned companies [7] - Nextensa NV is a mixed-use real estate investor and developer, with a total investment portfolio value of approximately €1.1 billion as of 30 June 2025 [10][11] Market Information - Nextensa's investment portfolio is geographically diversified, with 32% in Luxembourg, 51% in Belgium, and 17% in Austria [10] - The company is listed on Euronext Brussels, with a market capitalization of €426 million as of 30 June 2025 [12]

Group 1 - Morgan Stanley has crossed the 3% threshold in voting rights for Solvay, with a total of 3.96% after the transaction on June 25, 2025 [1][4] - The notification was sent to Solvay on July 1, 2025, in accordance with Belgian transparency legislation [1][4] - The total number of shares considered for the voting rights calculation is 105,876,416 [4] Group 2 - Solvay is a leading chemical company with a history dating back to 1863, focusing on sustainable solutions and innovation [3] - The company reported net sales of €4.7 billion in 2024 and employs approximately 9,000 people [3] - Solvay aims for a carbon-neutral future by 2050, emphasizing its commitment to sustainability [3]